Of note, flow cytometric analysis of unstimulated whole-blood samples revealed no significant enrichment in the percentage of IL-4+ or IL-17A+ lymphoid cell populations in COVID-19 patients relative to HVs (Supplemental Figure 11B). This evidence concerns the gene IL17A and COVID-19.